Sign In
Buy BMRN
$56.47
+1.81 (+3.31%)
At Close: Jun 04, 2026
Biomarin's Hemophilia A Drug Among 5 Up for FDA Approval Soon
07:57pm, Thursday, 09'th Jul 2020
If approved, company’s Roctavian would become first gene therapy for inherited disease Continue reading...
Biomarin’s Hemophilia A Drug Among 5 Up for FDA Approval Soon
02:57pm, Thursday, 09'th Jul 2020
Five pharmaceutical companies are awaiting approval of drugs in the next few months, and Biomarin Pharmaceutical Inc.
Abeona Restarts Enrollment in Connective Tissue Disorder Study
01:10pm, Thursday, 09'th Jul 2020
Abeona (ABEO) restarts patient enrollment in phase III VIITAL study of EB-101 for the treatment of recessive dystrophic epidermolysis bullosa.
BioMarin Pharmaceutical (NASDAQ:BMRN) Shareholders Booked A 54% Gain In The Last Year
07:31pm, Wednesday, 08'th Jul 2020
If you want to compound wealth in the stock market, you can do so by buying an index fund. But you can significantly...
Unum Therapeutics (UMRX) Catches Eye: Stock Jumps 8.6%
12:45pm, Wednesday, 08'th Jul 2020
Unum Therapeutics (UMRX) saw a big move last session, as its shares jumped nearly 9% on the day, amid huge volumes.
The Daily Biotech Pulse: Intersect ENT Jumps On M&A Speculation, VIVUS Files For Bankruptcy
12:00am, Wednesday, 08'th Jul 2020
Here's a roundup of top developments in the biotech space over the last 24 hours.
Scaling The Peaks
(Biotech Stocks Hitting 52-week Highs July 7)
AbbVie Inc (NYSE: ABBV)...
Were Hedge Funds Right About Piling Into BioMarin Pharmaceutical Inc. (BMRN)?
07:14pm, Tuesday, 07'th Jul 2020
The latest 13F reporting period has come and gone, and Insider Monkey is again at the forefront when it comes to making use of this gold mine of data. We at Insider Monkey have plowed through 821 13F
IPO Update: Inventiva SA Looks For $102 Million U.S. IPO (Pending:IVA)
09:58pm, Monday, 06'th Jul 2020
Inventiva SA has filed proposed terms for a U.S. IPO of $102 million.
Citigroup Increases BioMarin Pharmaceutical (NASDAQ:BMRN) Price Target to $148.00
07:34am, Monday, 06'th Jul 2020
BioMarin Pharmaceutical (NASDAQ:BMRN) had its target price boosted by equities research analysts at Citigroup from $105.00 to $148.00 in a research note issued on Monday, The Fly reports. The firm cur
Analysts' Top Healthcare Picks: Bristol Myers (BMY), Viking Therapeutics (VKTX) - Markets
03:58pm, Thursday, 02'nd Jul 2020
There’s a lot to be optimistic about in the Healthcare sector as 3 analysts just weighed in on Bristol Myers
Here's a roundup of top developments in the biotech space over the last 24 hours:
Scaling The Peaks
(Biotech Stocks Hitting 52-week Highs July 1)
AbbVie Inc (NYSE: ABBV)
ADC...
These stocks, including Tesla and Apple, are the real winners for the second quarter of 2020
10:24am, Wednesday, 01'st Jul 2020
A select group of stocks rose in the second quarter and for all of 2020.
The following is a roundup of top developments in the biotech space over the last 24 hours:Scaling The Peaks (Biotech Stocks Hitting 52-week Highs June 29) * ADC Therapeutics SA (NYSE: ADCT) * Altim
The following is a roundup of top developments in the biotech space over the last 24 hours:
Scaling The Peaks
(Biotech Stocks Hitting 52-week Highs June 29)
ADC Therapeutics SA (...
